EpiVax Announces Licensing of COVID-19 Vaccine Candidate to Ep...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PROVIDENCE, R.I., Aug. 26, 2020 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax"), a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate, EPV-CoV-19, to EpiVax Therapeutics ("EVT"), a New York-based...
Authors: LATEST ASIANET NEWS RELEASES